Continue Reading
Full article on Bloomberg
3SBio Sees More Business Development Deals
Market Intelligence Analysis
AI-Powered
Why This Matters
3SBio's CFO, Tony He, is optimistic about future business development deals, citing the company's record licensing agreement with Pfizer as a positive indicator.
Market Impact
Market impact analysis based on bullish sentiment with 80% confidence.
Sentiment
Bullish
AI Confidence
80%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Tony He, CFO of the Chinese biopharmaceutical firm 3SBio, discusses his outlook for dealmaking and the progress of a record licensing deal the company struck with Pfizer last year. He speaks on “Bloomberg: The China Show” from San Francisco, where the JPMorgan Healthcare Conference is taking place. (Source: Bloomberg)
Original article published by
Bloomberg
on January 15, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.